Vincent Cottin

Active 1996–2026

337
Papers
59,026
Citations
113
h-index
317
i10-index

Citations

Citations per year for Vincent Cottin1997: 2 citations2000: 6 citations2001: 4 citations2002: 15 citations2003: 21 citations2004: 20 citations2005: 18 citations2006: 25 citations2007: 40 citations2008: 37 citations2009: 50 citations2010: 72 citations2011: 79 citations2012: 123 citations2013: 171 citations2014: 213 citations2015: 350 citations2016: 366 citations2017: 416 citations2018: 482 citations2019: 1,886 citations2020: 2,354 citations2021: 2,640 citations2022: 2,255 citations2023: 1,696 citations2024: 2,978 citations2025: 1,198 citations2026: 36 citations1998–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,591 citing papers, 20.9% of this breakdownChina: 1,406 citing papers, 8.2% of this breakdownUnited Kingdom: 1,372 citing papers, 8% of this breakdownFrance: 1,162 citing papers, 6.7% of this breakdownItaly: 1,106 citing papers, 6.4% of this breakdownGermany: 1,077 citing papers, 6.3% of this breakdownJapan: 912 citing papers, 5.3% of this breakdownCanada: 692 citing papers, 4% of this breakdownNetherlands: 585 citing papers, 3.4% of this breakdownAustralia: 501 citing papers, 2.9% of this breakdownSpain: 481 citing papers, 2.8% of this breakdownSwitzerland: 404 citing papers, 2.3% of this breakdown
0%20.9%Other 22.8%

Fields

  • Medicine89.8%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Immunology and Microbiology2%
  • Engineering0.8%
  • Environmental Science0.4%
  • Neuroscience0.2%
  • Other1.2%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis18.2%
  • Pulmonary Hypertension Research and Treatments6.3%
  • Systemic Sclerosis and Related Diseases5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4%
  • Inflammatory Myopathies and Dermatomyositis3.3%
  • Sarcoidosis and Beryllium Toxicity Research3.2%
  • Other60%

Coauthors

All papers

Open in search
  1. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 4,611

  2. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 cited by 4,100

  3. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 2,346

  4. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 cited by 4,273

  5. Spectrum of Fibrotic Lung Diseases

    Authors: , - New England Journal of Medicine 2020 cited by 721

  6. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 1,444

  7. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

    Authors: , , , , , , , , , , - The Lancet Respiratory Medicine 2019 cited by 630

  8. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Blaas, Benjamin Bondue, Francesco Bonella, E. James Britt, Ketan Buch, John R. Burk, Hourong Cai, André M. Cantin, D.M. Castillo Villegas, Agustina Díaz Cazaux, Stefania Cerri, Said Chaaban, Nazia Chaudhuri, Vincent Cottin, Bruno Crestani, Gerard J. Criner, Caroline Dahlqvist, Sonye K. Danoff, J. Dematte D'Amico, Daniel F. Dilling, Paulo Eduardo Elias, Neil Ettinger, Jeremy Falk, Evans R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, Alex H. Gifford, Marilyn K. Glassberg, Craig S. Glazer, Jeffrey A. Golden, Luis Gómez Carrera, Julien Guiot, Robert W. Hallowell, Hiroki Hayashi, J. Hetzel, Nik Hirani, L. Homik, Benjamin Hope-Gill, David Hotchkin, Kazuya Ichikado, M. M. Ilkovich, Yoshikazu Inoue, Shinyu Izumi, Ewa Jassem, Leonie Jones, S. Jouneau, Robert J. Kaner, Jian Kang, Tsuyoshi Kawamura, Romain Kessler, Y. Kim, Kazuma Kishi, Hideya Kitamura, Martin Kolb, Yasuhiro Kondoh, Chiyoko Kono, Dirk Koschel, Michael Kreuter, Tejaswini Kulkarni, Jan Kuś, F. Lebargy, Antonio León Jiménez, Qun Luo, Yolanda Mageto, Toby M. Maher, Shigeki Makino, S. Marchand‐Adam, Charles‐Hugo Marquette, Raquel Martínez, Martin Ulises Gutierrez Martinez and 68 more - The Lancet Respiratory Medicine 2020 cited by 559

  9. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , - New England Journal of Medicine 2022 cited by 217

  10. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 cited by 502

  11. Progressive pulmonary fibrosis: an expert group consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 233

  12. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

    Authors: , , , , , , , , , , - European Respiratory Review 2018 cited by 653

  13. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Authors: , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2015 cited by 1,092

  14. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

    Authors: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 cited by 346

  15. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamera J. Corte, Ian Glaspole, Nicole Goh, Mark Holmes, M.A. Malouf, Francis Thien, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Antoine Froidure, Hans Slabbynck, Wim Wuyts, Claudia Cartagena Salinas, Rosa Feijoó Seoane, Victor D. Martínez, Roxana Maturana, Juana Pavie Gallegos, Andrés Rosenblüt, Rafael Silva, Alvaro Undurraga Pereira, Martina Doubková, Norbert Pauk, Martina Plačková, Martina Šterclová, Elisabeth Bendstrup, Saher Burhan Shaker, Ingrid Louise Titlestad, Stephan Budweiser, Christian Grohé, Dirk Koschel, Michael Kreuter, Antje Prasse, Michael Weber, Hubert Wirtz, Κατερίνα Αντωνίου, Zoe Daniil, Mina Gaga, Despoina Papakosta, Shinyu Izumi, Masaki Okamoto, Alfredo Guerreros Benavides, Carlos Barrera, Alejandro Manuel Peña Villalobos, Aranzazu Campo Ezquibela, José M. Cifrián, Estrella Fernández Fabrellas, Virginia Leiro, María Molina‐Molina, Asunción Nieto Barbero, Jacobo Sellarés, Claudia Valenzuela, Shih-Lung Cheng, Ping‐Hung Kuo, Kang‐Yun Lee, Chau‐Chyun Sheu, Hakan Günen, Nesrin Moğulkoç, Sibel Naycı, Huzaifa Adamali, Stephen Bianchi, Nazia Chaudhuri, Michael Gibbons, Simon P. Hart, Philip L. Molyneaux, Helen Parfrey, Gauri Saini, Lisa Spencer, Sarah Wiscombe, Danielle Antin‐Ozerkis, Rebecca Bascom and 152 more - JAMA 2023 cited by 127

  16. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2023 cited by 298

  17. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 cited by 198

  18. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 cited by 1,387

  19. Fibrosing interstitial lung diseases: knowns and unknowns

    Authors: , , , , , - European Respiratory Review 2019 cited by 338

  20. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 700

  21. The Lung in Rheumatoid Arthritis

    Authors: , , , , - Arthritis & Rheumatology 2018 cited by 299

  22. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 280

  23. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Athol U. Wells - American Journal of Respiratory and Critical Care Medicine 2022 cited by 226

  24. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

    Authors: , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 218